The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a $38,454 firm-fixed price contract to Bio-Rad AbD Serotec GmbH, a subsidiary of Bio-Rad Laboratories, Inc., to provide lab testing services for custom monoclonal recombinant antibodies generated through HuCAL technology. The contract will support the generation of monoclonal recombinant antibodies that the NIAID lab will use for in-vitro...
This federal contract was awarded by the Department of the Interior US Geological Survey Office of Acquisitions and Grants to Gene Infinity LLC, doing business as Antibody Design Labs, for the development of a phage library. The contract has a potential value of $7,169.00 and is a firm fixed price purchase order. The place of performance is San Diego, CA 92117. The contract does not have a set-aside designation. Based on the description, this contract appears to be for the development of phage...
Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...
This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
This $24,970 firm fixed price purchase order was awarded by the National Heart, Lung and Blood Institute of the National Institutes of Health to BioLegend, Inc., a medical division of Revvity Inc., to supply a custom human antibody panel. The solicitation requested TotalSeq-C Custom Human Panels consisting of 11 pouches with 5 reactions per pouch, for a total of 53 reactions. This antibody panel will support the Laboratory of Myeloid Malignancies' single-cell genomics and proteomics research...
This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...
The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
This is a $24,617.45 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Meso Scale Diagnostics LLC, a for-profit limited liability company. The contract is for screening monoclonal antibodies against proteins of interest, with a period of performance through July 31, 2024. No small business set-aside was used. Meso Scale Diagnostics is an...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), to Pacific Immunology, a USA-based biotech company located in Ramona, California. The contract is for the production of monospecific antibodies, with a ceiling value of $4,321.60 and an ultimate completion date of March 10, 2010. The contract does not utilize a set-aside designation. Pacific Immunology, the prime...